Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription 25.11.2024 7 Ann Surg Oncol 2 BMC Cancer 3 BMC Gastroenterol 1 Cancer Lett 2 Gastroenterology 1 Gastrointest Endosc 1 Gut 2 Int J Cancer 4 Int J Colorectal Dis 2 J Clin Oncol 4 J Surg Oncol 1 Minerva Gastroenterol (Torino) 1 Oncogene 1 Oncol Rep 4 PLoS One 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. NOZAWA H, Ito S, Sasaki K, Murono K, et al
   Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study.
   Ann Surg Oncol. 2024 Nov 18. doi: 10.1245/s10434-024-16537.
   PubMed         Abstract available
   
   
2. MEN V, Bahl P, Jin JZ, Singh PP, et al
   ASO Visual Abstract: Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
   Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16513.
   PubMed        
   
   
3. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
   Disparities in Palliative Treatment Utilization in Metastatic Colorectal Cancer Patients.
   Ann Surg Oncol. 2024 Nov 22. doi: 10.1245/s10434-024-16577.
   PubMed         Abstract available
   
   
4. KHORFAN R, Sedighim S, Caba-Molina D, Tran TB, et al
   National Trends and Outcomes in Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases Before and After PRODIGE 7.
   Ann Surg Oncol. 2024 Nov 21. doi: 10.1245/s10434-024-16539.
   PubMed        
   
   
5. MEN V, Jin JZ
   ASO Author Reflections: Lymph Node Yield and Long-Term Survival in Colon Cancer-Insights from a 20-Year National Study.
   Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16565.
   PubMed        
   
   
6. LIU D, Yang K, Cai J
   ASO Author Reflections: Organoid Model to Aid the Decision of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
   Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16555.
   PubMed        
   
   
7. ZHENG J, Wang T, Wang S, Ji H, et al
   ASO Author Reflections: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
   Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16576.
   PubMed        
   
   

   
   BMC Cancer

8. LI M, Li Z, Wu X, Yubo Pan, et al
   Exploring the correlation between Tom1L1 and the efficacy of neoadjuvant chemotherapy for locally progressive mid-low rectal cancer.
   BMC Cancer. 2024;24:1413.
   PubMed         Abstract available
   
   
9. CHEN Z, Cao H, Zhang J, Zhong W, et al
   The impact of preoperative treatment on mismatch repair protein and HER2 expression in colorectal cancer: an analysis of paired samples.
   BMC Cancer. 2024;24:1407.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. MEIRSON T, Markel G, Goldstein DA
    Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data.
    BMC Gastroenterol. 2024;24:414.
    PubMed         Abstract available
    
    
11. JIA CZ
    Long-term outcomes of additional surgery versus surveillance-only clinical decision for early colorectal cancer patients after non-curative endoscopic resection: a meta-analysis.
    BMC Gastroenterol. 2024;24:416.
    PubMed         Abstract available
    
    
12. RANJBAR ZAHEDANI M, Kazemi I, Kohanmoo A, Shateri Z, et al
    The association between non- and pro-healthy diet indices and the risk of colorectal cancer: a case-control study.
    BMC Gastroenterol. 2024;24:419.
    PubMed         Abstract available
    
    

    
    Cancer Lett

13. MALIER M, Laverriere MH, Henry M, Yakoubi M, et al
    Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase.
    Cancer Lett. 2024;606:217307.
    PubMed         Abstract available
    
    

    
    Gastroenterology

14. AMBESKOVIC A, McCall MN, Woodsmith J, Juhl H, et al
    Exon-Skipping-Based Subtyping of Colorectal Cancers.
    Gastroenterology. 2024;167:1358-1370.
    PubMed         Abstract available
    
    
15. CAO S, Nguyen K, Ma K, Du X, et al
    Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic Targets.
    Gastroenterology. 2024 Jul 29:S0016-5085(24)05284.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

16. MEDAWAR E, Djinbachian R, Rex D, Vieth M, et al
    Clinical Management of Patients with Colorectal Intramucosal Carcinoma Compared to High-Grade Dysplasia and T1 Colorectal Cancer.
    Gastrointest Endosc. 2024 Nov 16:S0016-5107(24)03731.
    PubMed         Abstract available
    
    

    
    Gut

17. SCHWARZMUELLER LJ, Adam RS, Moreno LF, Nijman LE, et al
    Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome.
    Gut. 2024 Nov 19:gutjnl-2024-332752. doi: 10.1136/gutjnl-2024-332752.
    PubMed         Abstract available
    
    

    
    Int J Cancer

18. OGUZ ERDOGAN AS, Simmer F, Nagtegaal ID
    Tumor deposits should not be placed in the M category of TNM: A comparative survival analysis using SEER data.
    Int J Cancer. 2025;156:274-279.
    PubMed         Abstract available
    
    
19. FENG X, Yao Q, Xu Y, Zhang J, et al
    Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma.
    Int J Cancer. 2024;155:1780-1791.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

20. MORAWSKA I, Pasicz K, Cieszanowski A
    Biomarkers of systemic treatment response: MR images of intratumoral fat deposition in colorectal liver metastases (CRLM) after chemotherapy.
    Int J Colorectal Dis. 2024;39:185.
    PubMed         Abstract available
    
    
21. TANG W, Li F, Zheng H, Zhao J, et al
    Prognostic Value of Baseline Skeletal Muscle Index in Colorectal Cancer Patients Treated with Fruquintinib: A multi-center real world analysis.
    Int J Colorectal Dis. 2024;39:186.
    PubMed         Abstract available
    
    
22. PARDES HY, Dohrn N, Dolin TG, Gogenur I, et al
    Patient-reported performance status and postoperative complications in elective colorectal cancer surgery.
    Int J Colorectal Dis. 2024;39:187.
    PubMed         Abstract available
    
    
23. ASAYAMA N, Nagata S, Shigita K, Mouri Y, et al
    Clinical outcome and long?term prognosis after endoscopic submucosal dissection for colorectal tumors in patients aged 75 years or older: a retrospective observational study.
    Int J Colorectal Dis. 2024;39:188.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

24. AVALLONE A, Giuliani F, De Stefano A, Santabarbara G, et al
    Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial.
    J Clin Oncol. 2024 Nov 22:JCO2400979. doi: 10.1200/JCO.24.00979.
    PubMed         Abstract available
    
    
25. 
    Erratum: Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.
    J Clin Oncol. 2024 Nov 19:JCO2402458. doi: 10.1200/JCO-24-02458.
    PubMed        
    
    

    
    J Surg Oncol

26. ADERIBIGBE AS, Dare AJ, Kalvin HL, Olasehinde O, et al
    Analysis of Risk Factors, Treatment Patterns, and Survival Outcomes After Emergency Presentation With Colorectal Cancer: A Prospective Multicenter Cohort Study in Nigeria.
    J Surg Oncol. 2024 Nov 21. doi: 10.1002/jso.27878.
    PubMed         Abstract available
    
    
27. ARAUJO SEA, Seid VE, Portilho AS, Horcel LA, et al
    Robot-assisted transanal minimally invasive surgery for the treatment of rectal adenocarcinoma.
    J Surg Oncol. 2024;130:844-845.
    PubMed         Abstract available
    
    
28. GERBASI LS, Tustumi F, Seid VE, Araujo SEA, et al
    Does Tri-Staple technology reduce the risk of anastomotic leakage in colorectal surgery? A propensity score matching analysis.
    J Surg Oncol. 2024;130:830-837.
    PubMed         Abstract available
    
    
29. VALADAO M, Riechelmann RP, Silva JACE, Mali J, et al
    Brazilian Society of Surgical Oncology: Guidelines for the management of anal canal cancer.
    J Surg Oncol. 2024;130:810-829.
    PubMed         Abstract available
    
    

    
    Minerva Gastroenterol (Torino)

30. LIU J, Zhang N, Li B, Cai S, et al
    Application of artificial intelligence combined with MDT teaching model in colorectal cancer training teaching.
    Minerva Gastroenterol (Torino). 2024 Nov 19. doi: 10.23736/S2724-5985.24.03784.
    PubMed        
    
    

    
    Oncogene

31. ZHUANG M, Liu J, Li Y, Zhang J, et al
    PD-L1 promotes tumor metastasis by regulating the infiltration of FGFBP2(+)Tm cells in colorectal cancer.
    Oncogene. 2024 Nov 18. doi: 10.1038/s41388-024-03223.
    PubMed         Abstract available
    
    

    
    Oncol Rep

32. CHE XH, Chen CL, Ye XL, Weng GB, et al
    [Retracted] Dual inhibition of COX?2/5?LOX blocks colon cancer proliferation, migration and invasion in vitro.
    Oncol Rep. 2025;53:12.
    PubMed         Abstract available
    
    

    
    PLoS One

33. 
    Expression of Concern: Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-kappaB and Src Protein Kinase Signaling Pathways.
    PLoS One. 2024;19:e0314637.
    PubMed        
    
    
34. CORREA-MEDERO RL, Pai R, Ebare K, Buchanan DD, et al
    Causal debiasing for unknown bias in histopathology-A colon cancer use case.
    PLoS One. 2024;19:e0303415.
    PubMed         Abstract available
    
    
35. GHOBASHI AH, Kimani JW, Ladaika CA, O'Hagan HM, et al
    PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells.
    PLoS One. 2024;19:e0313769.
    PubMed         Abstract available
    
    
36. DENG LQ, Li SY, Xie T, Zeng WQ, et al
    LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/beta-catenin regulatory axis.
    PLoS One. 2024;19:e0312417.
    PubMed         Abstract available
    
    

    
    World J Surg

37. LUCOCQ J, Trinder T, Symeonidou E, Homyer K, et al
    Long-term outcomes following the resection of screen-detected right-sided colon cancer.
    World J Surg. 2024 Nov 19. doi: 10.1002/wjs.12409.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.